Tag: terms

NORTHBROOK, Ill., July 30, 2025 /PRNewswire/ -- Stepan Company (NYSE: SCL) today reported: ...

Two Core Drill Rigs Arriving in August WINNEMUCCA, Nev., July 30, 2025 /PRNewswire/ -- Hycroft Mining Holding Corporation (Nasdaq: HYMC) ("Hycroft" or the "Company") today...

Acquisition strengthens Harrison Street’s European platform and expands credit, student housing and hospitality capabilities

Acquisition strengthens Harrison Street’s European platform and expands credit, student housing and hospitality capabilities

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, BC, July 30, 2025 /CNW/ - Palisades Goldcorp Ltd. (TSXV:...

ProLogium today unveiled its groundbreaking fourth-generation innovation—the Superfluidized Inorganic Solid-State Electrolyte

CONSHOHOCKEN, Pa., July 30, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) (“Madrigal”) today announced that it has entered into an exclusive global license agreement with CSPC Pharmaceutical Group Limited (HKEX Stock CodeL 1093) (“CSPC”) for SYH2086, a preclinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist and orforglipron derivative. Madrigal plans to initiate clinical development in the first half of 2026.

Key markets get boost in new shares exchange TAIPEI, July 30, 2025 /PRNewswire/ -- Hon Hai Technology Group ("Foxconn") (TWSE:2317) and TECO Electric & Machinery...

Key markets get boost in new shares exchange TAIPEI, July 30, 2025 /PRNewswire/ -- Hon Hai Technology Group ("Foxconn") (TWSE:2317) and TECO Electric & Machinery...

Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: 

KUALA LUMPUR, Malaysia, July 30, 2025 /PRNewswire/ -- Samsung's 2025 Mid Year Makeover Sale ends this 31 July 2025, and this is your final...

HONG KONG and SHANGHAI, July 30, 2025 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An", the "Company" or the "Group", HKEX:...

747 Media House leads cannabis SEO and dispensary marketing in 2025. Understand why it's the top-rated cannabis marketing agency driving revenue and compliance.

747 Media House leads cannabis SEO and dispensary marketing in 2025. Understand why it's the top-rated cannabis marketing agency driving revenue and compliance.

Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules

BALA CYNWYD, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the pricing of its previously announced underwritten public offering of 18,750,000 shares of its common stock at a price to the public of $3.20 per share. The aggregate gross proceeds to Larimar from this offering are expected to be $60.0 million, before deducting underwriting discounts and commissions and other offering expenses. In addition, Larimar has granted the underwriters a 30-day option to purchase up to an additional 2,812,500 shares of its common stock at the public offering price, less underwriting discounts and commissions. All shares of common stock are being offered by Larimar. The offering is expected to close on or about July 31, 2025, subject to the satisfaction of customary closing conditions.